Trials / Completed
CompletedNCT03262818
Transvaginal Ultrasound and Photoacoustic Imaging of the Ovary
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Washington University School of Medicine · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The investigators have developed co-registered photoacoustic and ultrasound (US) imaging technique that allows the investigators to visualize tumor structure and functional changes simultaneously, which may potentially reveal early tumor angiogenesis development that is not available by US alone. The ability to detect early angiogenesis changes, as well as tumor morphology changes in the ovary, using a non-invasive imaging modality will greatly enhance the care for women.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Transvaginal ultrasound | -Will be performed by US technologists at Washington University School of Medicine and read by Dr. Cary Siegel or Dr. Kathryn Robinson |
| DEVICE | Ultrasound/Photoacoustic imaging | -The light illumination for the photoacoustic imaging system is provided by a wavelength-tunable Ti:Sapphire laser (LOTIS TII), optically pumped by an Nd:YAG laser (LOTIS TII) at 532 nm wavelength. |
Timeline
- Start date
- 2017-02-01
- Primary completion
- 2018-11-19
- Completion
- 2018-11-20
- First posted
- 2017-08-25
- Last updated
- 2018-11-23
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03262818. Inclusion in this directory is not an endorsement.